PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

被引：1
|
作者：
Addeo, Alfredo [1 ]
Banna, Giuseppe Luigi [2 ]
机构：
[1] Univ Hosp Geneva, Oncol Dept, CH-1205 Geneva, Switzerland
[2] Cannizzaro Hosp, Div Med Oncol, Catania, Italy
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2018年 / 7卷
关键词：
PD-L1; EXPRESSION; ATEZOLIZUMAB; NIVOLUMAB; DOCETAXEL; BLOCKADE; TRIAL; NSCLC;
D O I：
10.21037/tlcr.2018.07.10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S283 / S286
页数：4
相关论文
共 50 条
  • [1] PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S287 - S289
  • [2] Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Metro, Giulio
    Di Maio, Massimo
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S294 - S296
  • [3] Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Metro, Giulio
    Di Maio, Massimo
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S290 - S293
  • [4] ATLANTIC: a sea change in immunotherapy for oncogene-driven lung cancer?
    Lin, Jessica J.
    Gainor, Justin F.
    [J]. LANCET ONCOLOGY, 2018, 19 (04): : 438 - 439
  • [5] Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
    Vokes, Natalie I.
    Pan, Kelsey
    Le, Xiuning
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [6] Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
    Miura, Yosuke
    Sunaga, Noriaki
    [J]. CANCERS, 2018, 10 (08)
  • [7] EGFR: The Paradigm of an Oncogene-Driven Lung Cancer
    Riely, Gregory J.
    Yu, Helena A.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2221 - 2226
  • [8] Treatment of oncogene-driven non-small cell lung cancer
    Kastelijn, Elisabeth A.
    de Langen, Adrianus J.
    Peters, Bas J. M.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) : 300 - 307
  • [9] Immunotherapy in EGFR-Mutant and ALK-Positive Lung Cancer Implications for Oncogene-Driven Lung Cancer
    Gavralidis, Alexander
    Gainor, Justin F.
    [J]. CANCER JOURNAL, 2020, 26 (06): : 517 - 524
  • [10] Perception of Palliative Care and Prognostic Awareness of Lung Cancer Treatment in an Oncogene-Driven Lung Cancer Community
    Roy, U. Basu
    Elkins, I.
    Petrillo, L.
    Jacobson, M.
    Feldman, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S395 - S396
12345